Bioxcel Therapeutics Stock Investor Sentiment
| BTAI Stock | USD 2.28 0.15 7.04% |
Under 68 percent of all BioXcel Therapeutics' traders are curious in acquiring. The analysis of the overall investor sentiment regarding BioXcel Therapeutics suggests that a large number of traders are confidant. BioXcel Therapeutics' investing sentiment shows overall attitude of investors towards BioXcel Therapeutics.
Comfort Level 68
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use BioXcel Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward BioXcel Therapeutics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
BioXcel Historical Sentiment
Although BioXcel Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding BioXcel, such as negative comments on social media and news outlets, may cause fear in the market and push BioXcel Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of BioXcel.
BioXcel |
BioXcel Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards BioXcel Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about BioXcel Therapeutics that are available to investors today. That information is available publicly through BioXcel media outlets and privately through word of mouth or via BioXcel internal channels. However, regardless of the origin, that massive amount of BioXcel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BioXcel Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioXcel Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioXcel Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioXcel Therapeutics alpha.
BioXcel Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 225 shares by Frank Yocca of BioXcel Therapeutics at 0.3512 subject to Rule 16b-3 | 12/16/2024 |
2 | Acquisition by Mack David J. of 27089 shares of BioXcel Therapeutics subject to Rule 16b-3 | 12/31/2024 |
3 | Insider Trading | 01/15/2025 |
4 | BioXcel Therapeutics announces 1-for-16 reverse stock split - MSN | 02/18/2025 |
5 | Acquisition by Mack David J. of 1693 shares of BioXcel Therapeutics subject to Rule 16b-3 | 02/28/2025 |
6 | BioXcel Therapeutics Announces 14 Million Registered Direct Offering | 03/03/2025 |
7 | Disposition of 1693 shares by Mack David J. of BioXcel Therapeutics subject to Rule 16b-3 | 03/04/2025 |
8 | Disposition of 521 shares by Steinhart Richard I of BioXcel Therapeutics subject to Rule 16b-3 | 03/06/2025 |
9 | BioXcel Therapeutics Announces 33 percent Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trialfor Acute Treatment of Agitation Associated with Bipolar Di... | 03/07/2025 |
10 | Acquisition by Mack David J. of 325077 shares of BioXcel Therapeutics subject to Rule 16b-3 | 03/10/2025 |
11 | Acquisition by Oneill Vincent of 21250 shares of BioXcel Therapeutics subject to Rule 16b-3 | 03/14/2025 |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |